About this trial
The aim of this prospective randomized double-blind study is to compare the effectiveness of routine antiemetic prophylaxis for the prevention of intraoperative nausea and vomiting (IONV) in non-fasted parturients undergoing emergency cesarean section under spinal anesthesia.
Nausea and vomiting are common complications during cesarean delivery performed under spinal anesthesia and may negatively affect maternal comfort and perioperative safety. The incidence of these symptoms may be particularly increased in emergency cesarean sections involving non-fasted (full-stomach) parturients. This study compares two commonly used antiemetic strategies, namely 5-hydroxytryptamine-3 (5-HT3) receptor antagonists and dopamine receptor antagonists, to determine their relative effectiveness in preventing IONV during surgery.
The findings are expected to contribute to optimization of antiemetic prophylaxis protocols, improvement of maternal comfort, and reduction of perioperative complications associated with nausea and vomiting during emergency cesarean delivery.
Eligibility criteria
Qualifiers
Pregnant women scheduled for emergency cesarean delivery under spinal anesthesia
Non-fasted (full-stomach) parturients
American Society of Anesthesiologists (ASA) physical status I-II
Age ≥ 18 years
Disqualifiers
ASA physical status III or higher
Refusal to participate
Elective cesarean delivery (non-emergency cases)
Preoperative antiemetic use within 24 hours before surgery
Trial design
Treatments tested in this trial
- Ondansetron 4mg
- metoclopramide